EMA Revamp Could Be Hampered By Tight Budget And Staffing
This article was originally published in The Tan Sheet
The European Medicines Agency plans a major restructuring plan to better aid its stakeholders, including firms considering OTC switch proposals or introducing other new OTCs, but tight staffing levels and budget stagnation could hamper the effort.
You may also be interested in...
The European Medicines Agency is focusing on transparency and pharmacovigilance over the next year, while the pharmaceutical industry is gearing up for a fight against austerity measures.
DuPont elbows out Danisco execs
The European Parliament blocks approval of EMA's budget accounts, citing handling of Mediator and broader conflict of interest concerns.